Time-dependent decision analysis: Stable disease in azacitidine (AZA)-treated patients (pts) with higher-risk MDS

被引：2

作者：

Gore, S.

Fenaux, P.

Santini, V.

Bennett, J. M.

Silverman, L. R.

Seymour, J. F.

Hellstrom-Lindberg, E.

Swern, A. S.

Beach, C. L.

List, A. F.

机构：

[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[2] Hop Avicenne, F-93009 Bobigny, France

[3] UF Ematol AOU Careggi Univ Florence, Florence, Italy

[4] Univ Rochester, Med Ctr, Rochester, NY 14642 USA

[5] Mt Sinai Sch Med, New York, NY USA

[6] Peter MacCallurn Canc Ctr, Melbourne, Vic, Australia

[7] Karolinska Univ Hosp, Stockholm, Sweden

[8] Celgene Corp, Summit, NJ USA

[9] Celgene Corp, Overland Pk, KS USA

[10] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA

来源：

关键词：

D O I：

10.1200/jco.2010.28.15_suppl.6503

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6503

引用

页数：1